Later On

A blog written for those whose interests more or less match mine.

The old self-regulation ploy

leave a comment »

Businesses are quick to propose that they can regulate themselves and therefore regulatory legislation (and regulatory agencies) are totally unnecessary. And somehow, some politicians still fall for it, even though the history of self-regulation is replete with failures (except for covering up problems, which self-regulation excels at). Businesses, not to put too fine a point on it, are simply not trustworthy. They require continual oversight and monitoring—as does any human institution. Look at the state we’re in today because Congress lacks effective oversight and monitoring. (Oversight and monitoring of Congress was formerly done by a free, combative, and competitive press and a watchful citizenry, but now the news outlets are all owned by major corporations, and it’s in their interest to coddle and pay off Congress so that things like “self-regulation” can flourish.) At any rate, look at this story:

The Pharmaceutical Research and Manufacturers of America (PhRMA) has announced a ban on giving branded items to doctors. The pens, notepads, mugs and other gifts are ubiquitous in medical offices. Some, like Senator Herb Kohl, think it is a step in the right direction. “We’ve been pushing to see reforms like this for some time now. Consumers will undoubtedly be the beneficiaries of these industry changes.” But the voluntary code does nothing to stem the more egregious ways that drug companies influence doctors, including speaking fees and lavish “educational” events. Kohl has co-sponsored a bill to require drug and medical device companies to publicly disclose payments to doctors of $500 or more, but does not ban them. Industry watchdogs are not convinced. One complained that “It strikes me as an attempt to persuade people against doing anything that’s serious.” The industry’s new policy, the Code on Interactions with Health Care Professionals, “will ask the chief executives of large drug makers to certify in writing that ‘they have policies and procedures in place to foster compliance with the code.'” But because it is voluntary, there will be no accountability or regulation. Former U.S. Representative Billy Tauzin now heads PhRMA. Tauzin said, “This updated code fortifies our companies’ commitment to ensure their medicines are marketed in a manner that benefits patients and enhances the practice of medicine.” CMD staffer Anne Landman recently wrote about the perils of letting industries self-regulate.

Source: New York Times, July 10, 2008

Written by LeisureGuy

10 July 2008 at 2:30 pm

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.